Cargando…
Re-thinking the possible interaction between proton pump inhibitors and capecitabine
Proton Pump Inhibitors (PPI) rank within the top ten most prescribed medications in Europe and USA. A high frequency of PPI use has been reported amongst patients undergoing chemotherapy, to mitigate treatment-induced gastritis or gastro-oesophageal reflux. Several recent, mostly retrospective, obse...
Autores principales: | Jeong, Soo Hee, Molloy, Lara, Ang, Edmond, Helsby, Nuala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556389/ https://www.ncbi.nlm.nih.gov/pubmed/36098758 http://dx.doi.org/10.1007/s00280-022-04473-9 |
Ejemplares similares
-
Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome
por: Hiromoto, Shiori, et al.
Publicado: (2021) -
Possible Effects of Proton Pump Inhibitors on Hearing Loss Development
por: Wiciński, Michał, et al.
Publicado: (2019) -
Think zinc: Transient nutritional deficiency related to novel maternal
SLC30A2
mutation potentially precipitated by antenatal proton pump inhibitor exposure
por: Porter, Emma, et al.
Publicado: (2023) -
Proton pump inhibitors affect capecitabine efficacy in patients with stage II–III colorectal cancer: a multicenter retrospective study
por: Kitazume, Yoshiko, et al.
Publicado: (2022) -
Is it possible to use Proton Pump Inhibitors in COVID-19 treatment and prophylaxis?
por: Taştemur, Şeyma, et al.
Publicado: (2020)